Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LVTX - LAVA Therapeutics NV

IEX Last Trade
1.745
-0.085   -4.871%

Share volume: 51,223
Last Updated: Fri 30 Aug 2024 09:59:36 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$1.83
-0.09
-4.65%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-7.41%
1 Month
-17.72%
3 Months
-27.08%
6 Months
-18.98%
1 Year
-3.31%
2 Year
-31.91%
Key data
Stock price
$1.74
P/E Ratio 
0.00
DAY RANGE
N/A - $1.81
EPS 
$0.00
52 WEEK RANGE
$1.13 - $6.47
52 WEEK CHANGE
-$0.02
MARKET CAP 
46.006 M
YIELD 
N/A
SHARES OUTSTANDING 
26.289 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
1.22
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$43,488
AVERAGE 30 VOLUME 
$51,914
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news